G-CSF Administration in IVF in a Preferable Preceptive Endometrium Score

Launched by ISTISHARI ARAB HOSPITAL · May 21, 2017

Keywords

ClinConnect Summary

Placebo: CONTROL patients treated with PLACEBO (saline solution) from the day of embryo transfer through the day of beta hCG test Drug\& scratching CONTROL saline infusion every day from the day of embryo transfer through the day of beta HCG test Other Name: SALINE INFUSION Experimental: G-CSF group patients treated with G-CSF if the biopsy adhesive score 1-3 only

1. Endometrial scratching and adhesive factor score, day 21-24 cycle prior to IVF//0rv day 3 of IVF cycle not planned before.
2. Drug \&scratching : G-CSF group

1- 300 µg trans cervical intrauterine of G-CSF was administered at ...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • ALL Women aged \< 40 years who would be submitted to oocyte retrieval and embryo transfer IN IVF cycle.
• Exclusion Criteria:
• • • contraindications for G-CSF treatment (sickle cell disease, chronic neutropenia, known past or present malignancy, renal insufficiency, upper respiratory infection, pneumonia, and congenital fructose intolerance)